| Vertex Signs License Agreement with Orum Therapeutics to Develop Novel Degrader-Antibody Conjugates for Conditioning Agents |
Abstract
pdf
html
|
|
Lalit Mishra |
|
| Roche Signs US$1.82 B Deal with Ascidian for RNA-Targeting Neurology Programmes |
Abstract
pdf
html
|
|
Amit Kaushik |
|
| ANI Pharmaceuticals to Acquire Alimera Sciences for US$381 M |
Abstract
pdf
html
|
|
Ayush Saxena |
|
| Lilly to Acquire Morphic for US$3.2 B |
Abstract
pdf
html
|
|
Shweta Gupta |
|
| AbbVie Acquires Celsius Therapeutics and its IBD Portfolio for US$250 M |
Abstract
pdf
html
|
|
Ashish Tripathi |
|
